Q1Y

5-[(3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}piperidin-4-yl]-2-fluoro-N-[(2H-indazol-3-yl)methyl]benzamide

Created:	2019-09-06
Last modified:	2020-04-15

Find Related PDB Entry
1 entries where Q1Y is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	2
Bond Count	69
Aromatic Bond Count	22

2D diagram of Q1Y

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-[(3S,4R)-3-{[(2H-1,3-benzodioxol-5-yl)oxy]methyl}piperidin-4-yl]-2-fluoro-N-[(2H-indazol-3-yl)methyl]benzamide
Systematic Name (OpenEye OEToolkits)	5-[(3~{S},4~{R})-3-(1,3-benzodioxol-5-yloxymethyl)piperidin-4-yl]-2-fluoranyl-~{N}-(2~{H}-indazol-3-ylmethyl)benzamide
Formula	C₂₈ H₂₇ F N₄ O₄
Molecular Weight	502.537
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c6(OCC1C(CCNC1)c2ccc(c(c2)C(NCc4c3c(cccc3)nn4)=O)F)cc5c(OCO5)cc6
SMILES	CACTVS	3.385	Fc1ccc(cc1C(=O)NCc2[nH]nc3ccccc23)[CH]4CCNC[CH]4COc5ccc6OCOc6c5
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c([nH]n2)CNC(=O)c3cc(ccc3F)C4CCNCC4COc5ccc6c(c5)OCO6
Canonical SMILES	CACTVS	3.385	Fc1ccc(cc1C(=O)NCc2[nH]nc3ccccc23)[C@@H]4CCNC[C@H]4COc5ccc6OCOc6c5
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c([nH]n2)CNC(=O)c3cc(ccc3F)[C@@H]4CCNC[C@H]4COc5ccc6c(c5)OCO6
InChI	InChI	1.03	InChI=1S/C28H27FN4O4/c29-23-7-5-17(11-22(23)28(34)31-14-25-21-3-1-2-4-24(21)32-33-25)20-9-10-30-13-18(20)15-35-19-6-8-26-27(12-19)37-16-36-26/h1-8,11-12,18,20,30H,9-10,13-16H2,(H,31,34)(H,32,33)/t18-,20-/m0/s1
InChIKey	InChI	1.03	KGSBEYKVWODBRD-ICSRJNTNSA-N

Related Resource References

Resource Name	Reference
PubChem	146019255

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.